What Happened to Cannabis Industry?
The global cannabis industry has experienced significant growth and transformation, driven by a wave of state-level legalizations in the United States and landmark federal rescheduling efforts. Internationally, countries like Germany have legalized adult-use cannabis, while others, such as Thailand, have refined their policies, often shifting towards a medical-only focus. As of late 2026, the industry is navigating complex regulatory landscapes, aiming for federal clarity in the U.S. and grappling with market maturation challenges like price compression and evolving product trends.
Quick Answer
The cannabis industry is currently in a dynamic phase of expansion and regulatory evolution. In the U.S., 24 states and D.C. have legalized adult-use cannabis, with federal efforts underway in 2026 to reschedule marijuana from Schedule I to Schedule III of the Controlled Substances Act, a move that could significantly impact taxation and banking. Globally, Germany became a major European market for adult-use cannabis in 2024, while Thailand reversed its recreational stance to focus solely on medical use by mid-2025. The industry continues to grow, projected to reach nearly $47 billion in the U.S. by 2026, but faces challenges including market oversaturation and persistent federal banking restrictions.
📊Key Facts
📅Complete Timeline12 events
Maryland Voters Approve Adult-Use Cannabis
Maryland voters approved Question 4, a ballot referendum to legalize adult-use cannabis for individuals 21 and older, effective July 1, 2023. This set the stage for a regulated adult-use market in the state.
Minnesota Legalizes Recreational Cannabis
Governor Tim Walz signed House File 100 into law, making Minnesota the 23rd state to legalize recreational marijuana for adults 21 and over. The law allowed possession and home cultivation, with commercial sales expected in 2025.
Adult-Use Cannabis Becomes Legal in Maryland
Following voter approval in 2022, adults 21 and older in Maryland could legally possess, use, and grow small amounts of cannabis. Existing medical dispensaries were authorized to convert to dual medical and adult-use sales.
Ohio Voters Approve Recreational Cannabis
Ohio voters passed Issue 2, the Marijuana Legalization Initiative, making it the 24th state to legalize adult-use cannabis. The measure allowed for the sale, purchase, possession, and home cultivation of marijuana for adults 21 and older.
Czech Republic Legalizes Adult-Use Cannabis
The Czech Republic became the latest country to legalize adult-use cannabis, permitting home cultivation of up to three plants and possession of up to 100 grams.
Germany's Cannabis Act Takes Effect
Germany legalized adult-use cannabis, allowing adults aged 18 and over to possess up to 25 grams in public, 50 grams at home, and cultivate up to three plants for personal use. This made Germany the first major EU member state to adopt nationwide legalization.
Ohio Begins Recreational Cannabis Sales
Ohio's first dual-use dispensaries opened their doors to recreational consumers, marking the official start of adult-use cannabis sales in the state, following the approval of Issue 2 in November 2023.
Thailand Reverts to Medical-Only Cannabis Policy
Thailand officially changed its cannabis policy, restricting access to medical use only. Cannabis flowers were reclassified as controlled herbs requiring a doctor's prescription, reversing the 2022 decriminalization of recreational use.
President Trump Issues Executive Order to Expedite Rescheduling
President Trump issued an executive order instructing the U.S. Attorney General to expedite the rulemaking process for rescheduling marijuana to Schedule III of the Controlled Substances Act.
U.S. DOJ Reschedules Medical Cannabis to Schedule III
The U.S. Department of Justice issued a final order reclassifying FDA-approved marijuana-derived drug products and marijuana from state medical programs into Schedule III of the Controlled Substances Act. This marked a significant federal policy shift.
DEA Administrative Hearing on Broader Rescheduling Begins
The Drug Enforcement Administration (DEA) commenced an expedited administrative hearing to consider the broader rescheduling of marijuana from Schedule I to Schedule III of the Controlled Substances Act. The hearings were scheduled to conclude by July 15, 2026.
DEA Releases Rescheduling Hearing Transcript
The Drug Enforcement Administration released the full official transcript of the administrative hearing on the cannabis rescheduling proposal. The presiding Administrative Law Judge is expected to issue a recommendation on whether marijuana should move to Schedule III.
Follow this story
Get an email when this timeline gets a major update.
🔍Deep Dive Analysis
The cannabis industry has undergone a profound transformation, moving from a largely illicit market to a rapidly expanding legal sector driven by shifting public opinion, economic incentives, and evolving medical understanding. This evolution has been particularly pronounced in the United States and Europe, though not without its complexities and occasional reversals.
In the United States, the momentum for cannabis legalization has continued to build at the state level. By 2026, adult-use (recreational) cannabis is legal in 24 states and Washington D.C., with over 38 states having medical cannabis programs. Recent additions include Maryland, where adult-use became legal on July 1, 2023, following a 2022 ballot referendum. Minnesota followed suit, legalizing recreational use in August 2023, with retail sales expected to commence in early 2025. Ohio became the 24th state to legalize adult-use cannabis on November 7, 2023, with sales beginning in August 2024. This patchwork of state laws has created a robust, albeit fragmented, market that is projected to reach nearly $47 billion in the U.S. by 2026, contributing approximately $149 billion to the economy in 2025 and supporting over 425,000 full-time equivalent jobs.
A significant turning point in U.S. federal policy occurred in late 2025 and 2026. On December 18, 2025, President Trump issued an executive order instructing the U.S. Attorney General to expedite the rescheduling of marijuana to Schedule III of the Controlled Substances Act (CSA). This was followed by an order from Acting Attorney General Todd Blanche on April 22, 2026, which immediately placed FDA-approved marijuana products and state-licensed medical marijuana products into Schedule III. The Drug Enforcement Administration (DEA) subsequently announced an expedited administrative hearing, which commenced on June 29, 2026, and concluded by July 15, 2026, to consider the broader rescheduling of marijuana from Schedule I to Schedule III. This potential shift is crucial as it would alleviate the punitive 280E tax code for cannabis businesses, significantly improving profitability and reinvestment opportunities. However, rescheduling alone does not equate to full federal legalization, and major banks are expected to remain cautious until explicit safe harbor laws, such as the SAFER Banking Act, are passed.
Internationally, Germany made headlines by legalizing adult-use cannabis on April 1, 2024, becoming the first major European Union member state to do so. The law permits adults to possess limited amounts, cultivate up to three plants, and join non-profit cannabis social clubs starting July 1, 2024. Conversely, Thailand, which had decriminalized cannabis in 2022, reversed its stance on recreational use. By June 2025, Thailand officially shifted back to a medical-only market, classifying cannabis flowers as controlled herbs requiring prescriptions and licensed handling, aiming to curb misuse and regulate the burgeoning industry. The Czech Republic also legalized adult-use cannabis, permitting home cultivation and possession from January 1, 2026.
Despite the overall growth, the industry faces significant challenges. Market oversaturation in mature states like California and Oregon has led to price compression and reduced margins, causing a modest decline in overall cannabis jobs in 2025. Banking access remains a hurdle due to federal prohibition, although tech-driven financial infrastructure is improving payment processing alternatives like ACH transactions. Regulatory compliance is complex, with varying state advertising restrictions and evolving policies around hemp-derived THC products. Social equity initiatives continue to be a focus in many newly legalizing states, aiming to address historical harms of prohibition through preferential licensing and community reinvestment. As of August 27, 2026, the cannabis industry awaits the DEA's recommendation on broader rescheduling, which is expected to further shape its trajectory, while state markets continue to mature and adapt to a dynamic regulatory environment.
What If...?
Explore alternate histories. What if Cannabis Industry made different choices?